Jag Capital Management LLC Sells 9,346 Shares of Intuitive Surgical, Inc. $ISRG

Jag Capital Management LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.4% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 32,285 shares of the medical equipment provider’s stock after selling 9,346 shares during the period. Intuitive Surgical makes up 2.0% of Jag Capital Management LLC’s investment portfolio, making the stock its 17th biggest position. Jag Capital Management LLC’s holdings in Intuitive Surgical were worth $17,544,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Brighton Jones LLC boosted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. GAMMA Investing LLC increased its stake in Intuitive Surgical by 9.3% in the first quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $3,029,000 after purchasing an additional 518 shares in the last quarter. Elevation Point Wealth Partners LLC increased its stake in Intuitive Surgical by 16.1% in the first quarter. Elevation Point Wealth Partners LLC now owns 562 shares of the medical equipment provider’s stock valued at $278,000 after purchasing an additional 78 shares in the last quarter. Farmers & Merchants Investments Inc. increased its position in shares of Intuitive Surgical by 10.2% during the first quarter. Farmers & Merchants Investments Inc. now owns 259 shares of the medical equipment provider’s stock worth $128,000 after acquiring an additional 24 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC increased its position in shares of Intuitive Surgical by 0.8% during the first quarter. Dynamic Advisor Solutions LLC now owns 10,589 shares of the medical equipment provider’s stock worth $5,244,000 after acquiring an additional 81 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $435.73 on Tuesday. The firm has a market cap of $156.20 billion, a price-to-earnings ratio of 60.77, a PEG ratio of 4.51 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a 50-day moving average of $457.73 and a 200 day moving average of $497.44.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. During the same period last year, the business earned $1.78 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. UBS Group set a $529.00 target price on shares of Intuitive Surgical in a report on Monday. The Goldman Sachs Group decreased their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $584.76.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.